| Segment Reporting [Table Text Block] |
| | | Three Months Ended June 30, 2026 | |
| | | Scours | | | Mastitis | | | Other | | | Total | |
| Product sales | | $ | 7,110,769 | | | $ | 75,344 | | | $ | — | | | $ | 7,186,113 | |
| Costs of goods sold | | | 4,686,934 | | | | 61,957 | | | | — | | | | 4,748,891 | |
| Gross profit | | | 2,423,835 | | | | 13,387 | | | | — | | | | 2,437,222 | |
| | | | | | | | | | | | | | | | | |
| Administrative expenses | | | — | | | | — | | | | 1,271,909 | | | | 1,271,909 | |
| Sales and marketing expenses | | | 1,110,727 | | | | — | | | | — | | | | 1,110,727 | |
| Product development expenses (income), net(1) | | | 143,438 | | | | (52,495 | ) | | | 28,709 | | | | 119,652 | |
| Other operating income(2) | | | — | | | | (2,000,000 | ) | | | — | | | | (2,000,000 | ) |
| Operating expenses (income) | | | 1,254,165 | | | | (2,052,495 | ) | | | 1,300,618 | | | | 502,288 | |
| | | | | | | | | | | | | | | | | |
| NET OPERATING INCOME (LOSS) | | $ | 1,169,670 | | | $ | 2,065,882 | | | $ | (1,300,618 | ) | | $ | 1,934,934 | |
| | | Three Months Ended June 30, 2025 | |
| | | Scours | | | Mastitis | | | Other | | | Total | |
| Product sales | | $ | 6,398,517 | | | $ | 46,363 | | | $ | — | | | $ | 6,444,880 | |
| Costs of goods sold | | | 3,589,893 | | | | 37,063 | | | | — | | | | 3,626,956 | |
| Gross profit | | | 2,808,624 | | | | 9,300 | | | | — | | | | 2,817,924 | |
| | | | | | | | | | | | | | | | | |
| Administrative expenses | | | — | | | | — | | | | 720,418 | | | | 720,418 | |
| Sales and marketing expenses | | | 634,846 | | | | 61,240 | | | | — | | | | 696,086 | |
| Product development expenses | | | 93,011 | | | | 710,745 | | | | 28,102 | | | | 831,858 | |
| Operating expenses | | | 727,857 | | | | 771,985 | | | | 748,520 | | | | 2,248,362 | |
| | | | | | | | | | | | | | | | | |
| NET OPERATING INCOME (LOSS) | | $ | 2,080,767 | | | $ | (762,685 | ) | | $ | (748,520 | ) | | $ | 569,562 | |
| | | Six Months Ended June 30, 2026 | |
| | | Scours | | | Mastitis | | | Other | | | Total | |
| Product sales | | $ | 17,418,544 | | | $ | 124,864 | | | $ | — | | | $ | 17,543,408 | |
| Costs of goods sold | | | 10,354,685 | | | | 94,057 | | | | — | | | | 10,448,742 | |
| Gross profit | | | 7,063,859 | | | | 30,807 | | | | — | | | | 7,094,666 | |
| | | | | | | | | | | | | | | | | |
| Administrative expenses | | | — | | | | — | | | | 2,409,586 | | | | 2,409,586 | |
| Sales and marketing expenses | | | 2,336,687 | | | | 6,803 | | | | — | | | | 2,343,490 | |
| Product development expenses | | | 241,531 | | | | 115,904 | | | | 79,905 | | | | 437,340 | |
| Other operating income(1) | | | — | | | | (2,000,000 | ) | | | — | | | | (2,000,000 | ) |
| Operating expenses (income) | | | 2,578,218 | | | | (1,877,293 | ) | | | 2,489,491 | | | | 3,190,416 | |
| | | | | | | | | | | | | | | | | |
| NET OPERATING INCOME (LOSS) | | $ | 4,485,641 | | | $ | 1,908,100 | | | $ | (2,489,491 | ) | | $ | 3,904,250 | |
| | | Six Months Ended June 30, 2025 | |
| | | Scours | | | Mastitis | | | Other | | | Total | |
| Product sales | | $ | 14,427,003 | | | $ | 85,051 | | | $ | — | | | $ | 14,512,054 | |
| Costs of goods sold | | | 8,264,436 | | | | 75,722 | | | | — | | | | 8,340,158 | |
| Gross profit | | | 6,162,567 | | | | 9,329 | | | | — | | | | 6,171,896 | |
| | | | | | | | | | | | | | | | | |
| Administrative expenses | | | — | | | | — | | | | 1,343,260 | | | | 1,343,260 | |
| Sales and marketing expenses | | | 1,421,983 | | | | 130,761 | | | | — | | | | 1,552,744 | |
| Product development expenses | | | 186,496 | | | | 1,339,657 | | | | 62,552 | | | | 1,588,705 | |
| Operating expenses | | | 1,608,479 | | | | 1,470,418 | | | | 1,405,812 | | | | 4,484,709 | |
| | | | | | | | | | | | | | | | | |
| NET OPERATING INCOME (LOSS) | | $ | 4,554,088 | | | $ | (1,461,089 | ) | | $ | (1,405,812 | ) | | $ | 1,687,187 | |
|
| Total Assets, Depreciation and Amortization, and Capital Expenditures [Table Text Block] |
| | | Scours | | | Mastitis | | | Other | | | Total | |
| Total Assets as of June 30, 2026(1) | | $ | 37,524,605 | | | $ | 122,726 | | | $ | 8,982,465 | | | $ | 46,629,796 | |
| Total Assets as of December 31, 2025(1) | | $ | 38,245,418 | | | $ | 134,138 | | | $ | 4,152,891 | | | $ | 42,532,447 | |
| Depreciation expense during the three months ended June 30, 2026 | | $ | 463,271 | | | $ | — | | | $ | 7,350 | | | $ | 470,621 | |
| Depreciation and amortization expense during the three months ended June 30, 2025 | | $ | 345,512 | | | $ | 314,175 | | | $ | 19,350 | | | $ | 679,037 | |
| Capital Expenditures during the three months ended June 30, 2026 | | $ | 727,931 | | | $ | — | | | $ | 6,008 | | | $ | 733,939 | |
| Capital Expenditures during the three months ended June 30, 2025 | | $ | 151,808 | | | $ | 1,079 | | | $ | 2,271 | | | $ | 155,158 | |
| | | Scours | | | Mastitis | | | Other | | | Total | |
| Depreciation expense during the six months ended June 30, 2026 | | $ | 981,288 | | | $ | — | | | $ | 17,627 | | | $ | 998,915 | |
| Depreciation and amortization expense during the six months ended June 30, 2025 | | $ | 698,034 | | | $ | 628,834 | | | $ | 38,942 | | | $ | 1,365,810 | |
| Capital Expenditures during the six months ended June 30, 2026 | | $ | 886,663 | | | $ | 8,526 | | | $ | 15,980 | | | $ | 911,169 | |
| Capital Expenditures during the six months ended June 30, 2025 | | $ | 474,185 | | | $ | 7,752 | | | $ | 2,271 | | | $ | 484,208 | |
|